RAPS Euro Convergence 2026
Event details
RAPS Euro Convergence is the largest and most recognized event for regulatory professionals, bringing together industry leaders, innovators, and experts from around the globe. The congress is a platform for sharing the latest developments, best practices, and cutting-edge insights in regulatory affairs. With a diverse agenda of workshops, panel discussions, and networking opportunities, RAPS Euro Convergence is where the future of regulatory science and practice takes shape.
QbD Group, your life sciences partner across the entire product lifecycle
At RAPS 2026, our experts will share practical insights on navigating evolving global regulatory frameworks and clinical trial requirements. From international collaboration pathways to upcoming UK regulatory changes, we help you align strategy, compliance and execution across markets:
-
Navigating Global CTR–IVDR Trials – Align drug–diagnostic development across Europe, the UK and the US by addressing IVDR clinical obligations and operational challenges in combined trials.
-
New UK Clinical Trial Regulations – Prepare for the April 2026 UK CTR update with clarity on authorisation changes, approval timelines and strategic implications for sponsors.
-
CMC Strategy for First-in-Human – Build a practical CMC roadmap for early-phase development, covering formulation, stability, and regulatory expectations to accelerate your path to first-in-human trials.
Connect with our team of experts
Stop by and connect with our experts! Whether it's regulatory guidance, market access strategies, or quality systems, we're here to help you navigate the fast-changing healthcare landscape. Visit us at the exhibition or reach out today to see how we can accelerate your success in medical innovation.
Kirsten Van Garsse
Business Unit Manager RA IVD & Representative Services
Talk slot: Wednesday 6/5 | 12:00–13:00
Title: Navigating Global CTR–IVDR Trials: Real-World Challenges and Practical Lessons.
Dmitry Obolskiy
Senior Consultant RA | Team Lead | Associate Director
Talk slot: Thursday 7/5 | 14:30–15:30
Title: EU CTR, UK CTA Reform, and ICH E6(R3): Strategies for Clinical Trial Success in the EU and UK
Sacha Lynch
Principal Consultant RA | Senior Team Lead
Talk slot: Thursday 7/5 | 13:30–13:55
Title: CMC Strategy for First-in-Human: A Practical Roadmap for Development
Book a meeting with our life sciences consultants
In addition to our speakers, QbD Group's business development experts will also be attending the event. If you're exploring regulatory support, EU market entry, or want to discover how we can support your product journey from A to Z - don't hesitate to book a meeting.
Meet us at RAPS Euro Convergence 2026 or reach out today to schedule a conversation!
Yosri El-Achheb
Senior Business Development Manager MedTech
Over 13 years of experience in MedTech business development, specializing in EU MDR/IVDR compliance, clinical research, and international market access across 38 countries.
Marin Vrhovac
Business Development Manager Pharma
Business development professional with deep expertise in regulatory affairs, pharmacovigilance, and quality systems — supporting pharma and biotech companies across the full commercial lifecycle.